Skip to main content

Peer Review reports

From: TrkA is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines

Original Submission
1 Feb 2015 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
Resubmission - Version 8
Submitted Manuscript version 8
Author responded Author comments
Resubmission - Version 9
Submitted Manuscript version 9
Author responded Author comments
Resubmission - Version 10
Submitted Manuscript version 10
Resubmission - Version 11
Submitted Manuscript version 11
Author responded Author comments
Resubmission - Version 12
Submitted Manuscript version 12
Publishing
15 Oct 2015 Editorially accepted
24 Oct 2015 Article published 10.1186/s12885-015-1791-y

You can find further information about peer review here.

Back to article page